Sabrina Nebel

Ms. Sabrina Nebel

Department of Biotechnology, University of Natural Resources and Life Sciences, Vienna, Vienna, Wien, Austria
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 April 2021 in Cells
Verified
Journal Article
Open access
PDF file
INIlias Nikolits
Ilias Nikolits
SNSabrina Nebel
Sabrina Nebel
Dominik EggerDominik Egger
Dominik Egger
SKSebastian Kreß
Sebastian Kreß
Cornelia KasperCornelia Kasper
Cornelia Kasper
Mesenchymal stem cells (MSCs) are of great interest for their use in cell-based therapies due to their multipotent differentiation and immunomodulatory capacities. In consequence of limited numbers following their isolation from the donor tissue, MSCs require extensive expansion performed in traditional 2D cell culture setups to reach adequate amounts for therapeutic use. However, prolonged culture of MSCs in vitro has been shown to decrease their differentiation potential and alter their immunomodulatory properties. For that reason, preservation of these physiological characteristics of MSCs throughout their in vitro culture is essential for improving the efficiency of therapeutic and in vitro modeling applications. With this objective in mind, many studies already investigated certain parameters for enhancing current standard MSC culture protocols with regard to the effects of specific culture media components or culture conditions. Although there is a lot of diversity in the final therapeutic uses of the cells, the primary stage of standard isolation and expansion is imperative. Therefore, we want to review on approaches for optimizing standard MSC culture protocols during this essential primary step of in vitro expansion. The reviewed studies investigate and suggest improvements focused on culture media components (amino acids, ascorbic acid, glucose level, growth factors, lipids, platelet lysate, trace elements, serum, and xenogeneic components) as well as culture conditions and processes (hypoxia, cell seeding, and dissociation during passaging), in order to preserve the MSC phenotype and functionality during the primary phase of in vitro culture.

6 February 2022 in Bioengineering
Verified
Journal Article
Open access
PDF file
SNSabrina Nebel
Sabrina Nebel
MLManuel Lux
Manuel Lux
SKSonja Kuth
Sonja Kuth
FBFaina Bider
Faina Bider
WDWolf Dietrich
Wolf Dietrich
Cornelia KasperCornelia Kasper
Cornelia Kasper
Mesenchymal stem cells (MSCs) are primary candidates in tissue engineering and stem cell therapies due to their intriguing regenerative and immunomodulatory potential. Their ability to self-assemble into three-dimensional (3D) aggregates further improves some of their therapeutic properties, e.g., differentiation potential, secretion of cytokines, and homing capacity after administration. However, high hydrodynamic shear forces and the resulting mechanical stresses within commercially available dynamic cultivation systems can decrease their regenerative properties. Cells embedded within a polymer matrix, however, lack cell-to-cell interactions found in their physiological environment. Here, we present a “semi scaffold-free” approach to protect the cells from high shear forces by a physical barrier, but still allow formation of a 3D structure with in vivo-like cell-to-cell contacts. We highlight a relatively simple method to create core–shell capsules by inverse gelation. The capsules consist of an outer barrier made from sodium alginate, which allows for nutrient and waste diffusion and an inner compartment for direct cell-cell interactions. Next to capsule characterization, a harvesting procedure was established and viability and proliferation of human adipose-derived MSCs were investigated. In the future, this encapsulation and cultivation technique might be used for MSC-expansion in scalable dynamic bioreactor systems, facilitating downstream procedures, such as cell harvest and differentiation into mature tissue grafts.

20 January 2023
Verified
Book Chapter
Closed access
Dominik EggerDominik Egger
Dominik Egger
SNSabrina Nebel
Sabrina Nebel
MGMarius Gensler
Marius Gensler
SKSebastian Kreß
Sebastian Kreß
JHJan Hansmann
Jan Hansmann
CKCornelia Kasper
Cornelia Kasper

10 June 2021
Verified
Book Chapter
Closed access
PDF file
SKSebastian Kreß
Sebastian Kreß
CACiarra Almeria
Ciarra Almeria
SNSabrina Nebel
Sabrina Nebel
DFDaniel Faust
Daniel Faust
CKCornelia Kasper
Cornelia Kasper

10 June 2021
Verified
Book Chapter
Closed access
PDF file
Dominik EggerDominik Egger
Dominik Egger
SNSabrina Nebel
Sabrina Nebel